Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China

CompletedOBSERVATIONAL
Enrollment

1,378

Participants

Timeline

Start Date

June 26, 2015

Primary Completion Date

October 30, 2018

Study Completion Date

October 30, 2018

Conditions
Non-Small Cell Lung Cancer, Lung Cancer, Cancer
Interventions
OTHER

No intervention

No intervention administered in this study

Trial Locations (11)

100021

Cancer Hospital Chinese Academy of Medical Sciences., Beijing

130021

the First Hospital of Jilin University, Changchun

150081

Harbin Medical University Cancer Hospital, Harbin

200032

Zhongshan Hospital Fudan University, Shanghai

200080

Shanghai First People's Hospital, Shanghai

350014

Fujian Cancer Hospital, Fuzhou

400042

Third Affiliated Hospital of Third Military Medical University, Chongqing

430023

Union Hospital of Tongji Medical College, Dept. of Cancer Center; Cancer Center, Wuhan

530021

The First Affiliate Hospital of Guangxi Medical University, Nanning

610041

Sichuan Provincial Cancer Hospital, Chengdu

710061

First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02458651 - Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China | Biotech Hunter | Biotech Hunter